Results of endovascular therapy of the subclavian and innominate arteries in 63 patients
(2013) In Gazzetta Medica Italiana Archivio per le Scienze Mediche 172(1-2). p.1-9- Abstract
Aim. The aim of the study was to describe results from a single vascular unit of endovascular revascularisation of subclavian and innominate arterial disease. Methods. Between April 1994 and March 2010, 63 patients (mean age 61.8±10.8 years, 41[65%] women) were endovascularly treated for subclavian and innominate arterial disease. Fourteen (22%) had upper extremity claudication, 5 (8%) acute arm ischemia, 6 (10%) subclavian steal syndrome, 18 (29%) both these symptoms, and one had a subclavian aneurysm. Three (5%) had Takayasu's arteritis. Percutaneous transluminal angioplasty (PTA) with stent placement was performed in 55 (87%) patients, and only PTA in the remaining 8 (13%). Follow-up was clinical and with duplex ultrasound, computed... (More)
Aim. The aim of the study was to describe results from a single vascular unit of endovascular revascularisation of subclavian and innominate arterial disease. Methods. Between April 1994 and March 2010, 63 patients (mean age 61.8±10.8 years, 41[65%] women) were endovascularly treated for subclavian and innominate arterial disease. Fourteen (22%) had upper extremity claudication, 5 (8%) acute arm ischemia, 6 (10%) subclavian steal syndrome, 18 (29%) both these symptoms, and one had a subclavian aneurysm. Three (5%) had Takayasu's arteritis. Percutaneous transluminal angioplasty (PTA) with stent placement was performed in 55 (87%) patients, and only PTA in the remaining 8 (13%). Follow-up was clinical and with duplex ultrasound, computed tomography angiography (CTA) or magnetic resonance imaging (MRI) after 3, 6, and 12 months depending on recurrence of clinical symptoms. Results. Technical success was achieved in 63 (100%) patients. Systolic blood pressure difference between the brachial arteries was 74±57 mmHg before and 7±12 mmHg after intervention (P<0.02). Eleven of the 63 patients were lost to follow-up after initial management. The mean follow-up of the remaining 52 (83%) was 513±730 days, median 369 (IQR 70-569) days. Survival rate was 92% at 12 months. Primary patency was 88% at 11±10 months and secondary patency 96%. One patient had restenosis after 13 months and two patients with Takayasu's arteritis had restenosis after 1.5 and 6 months, re spectively. Fatal procedure related complications occurred in two patients. Conclusion. Endovascular therapy is a relatively safe and effective treatment for atherosclerotic disease in the subclavian and innominate arteries.
(Less)
- author
- Åkesson, M. ; Gottsäter, A. LU and Alhadad, A. LU
- publishing date
- 2013-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Arterial occlusive diseases, Stents, Subclavian steal syndrome
- in
- Gazzetta Medica Italiana Archivio per le Scienze Mediche
- volume
- 172
- issue
- 1-2
- pages
- 9 pages
- publisher
- Edizioni Minerva Medica S.p.A.
- external identifiers
-
- scopus:84876463984
- ISSN
- 0393-3660
- language
- English
- LU publication?
- no
- id
- f087402e-c6e0-49b9-8659-9920a02e7634
- date added to LUP
- 2020-12-11 14:18:08
- date last changed
- 2022-02-01 18:25:18
@article{f087402e-c6e0-49b9-8659-9920a02e7634, abstract = {{<p>Aim. The aim of the study was to describe results from a single vascular unit of endovascular revascularisation of subclavian and innominate arterial disease. Methods. Between April 1994 and March 2010, 63 patients (mean age 61.8±10.8 years, 41[65%] women) were endovascularly treated for subclavian and innominate arterial disease. Fourteen (22%) had upper extremity claudication, 5 (8%) acute arm ischemia, 6 (10%) subclavian steal syndrome, 18 (29%) both these symptoms, and one had a subclavian aneurysm. Three (5%) had Takayasu's arteritis. Percutaneous transluminal angioplasty (PTA) with stent placement was performed in 55 (87%) patients, and only PTA in the remaining 8 (13%). Follow-up was clinical and with duplex ultrasound, computed tomography angiography (CTA) or magnetic resonance imaging (MRI) after 3, 6, and 12 months depending on recurrence of clinical symptoms. Results. Technical success was achieved in 63 (100%) patients. Systolic blood pressure difference between the brachial arteries was 74±57 mmHg before and 7±12 mmHg after intervention (P<0.02). Eleven of the 63 patients were lost to follow-up after initial management. The mean follow-up of the remaining 52 (83%) was 513±730 days, median 369 (IQR 70-569) days. Survival rate was 92% at 12 months. Primary patency was 88% at 11±10 months and secondary patency 96%. One patient had restenosis after 13 months and two patients with Takayasu's arteritis had restenosis after 1.5 and 6 months, re spectively. Fatal procedure related complications occurred in two patients. Conclusion. Endovascular therapy is a relatively safe and effective treatment for atherosclerotic disease in the subclavian and innominate arteries.</p>}}, author = {{Åkesson, M. and Gottsäter, A. and Alhadad, A.}}, issn = {{0393-3660}}, keywords = {{Arterial occlusive diseases; Stents; Subclavian steal syndrome}}, language = {{eng}}, number = {{1-2}}, pages = {{1--9}}, publisher = {{Edizioni Minerva Medica S.p.A.}}, series = {{Gazzetta Medica Italiana Archivio per le Scienze Mediche}}, title = {{Results of endovascular therapy of the subclavian and innominate arteries in 63 patients}}, volume = {{172}}, year = {{2013}}, }